A Deep Dive into Osteoporosis Treatment Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

Which drivers are expected to have the greatest impact on the over the osteoporosis treatment market's growth?
The osteoporosis treatment market is set to grow, fueled by the rising prevalence and incidences of osteoporosis. Characterized by changes in bone strength and composition or a decrease in bone mass and mineral density, osteoporosis can be controlled largely through drugs that reduce the pace at which bones degenerate. Besides, hormone-based treatments like estrogen are effective in preserving bone density when used immediately post-menopause. Amgen, a biopharmaceutical firm based in the US, stated in May 2022 that the yearly count of fractures stemming from osteoporosis is predicted to surge by 68% to 3.2 million by 2040. Moreover, the National Library of Medicine, a health professionals' national resource in the US, reported in April 2022 that an estimated 549,000 new fragility fractures occur yearly in the UK, with men accounting for a third of these cases. Owing to an aging population, this figure is forecasted to climb by 19.6% come 2030. As such, the mounting prevalence and incidences of osteoporosis contribute to the expansion of the osteoporosis treatment market.

Get Your Osteoporosis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

What is the future CAGR of the osteoporosis treatment market, and how will it impact industry expansion?
The market size for osteoporosis treatment has consistently expanded in the past few years. From $13.96 billion in 2024, it is expected to rise to $14.62 billion in 2025, the Compound Annual Growth Rate (CAGR) being 4.8%. Factors contributing to the expansion during the historic period include the demographic of an aging population, the implementation of hormone replacement therapies, supplementation of calcium and vitamin D, enhanced diagnostic tools, and the incorporation of digital health solutions.

In the foreseeable future, the market size of osteoporosis treatment is poised for robust expansion. It's projected to hit $17.84 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.1%. The predicted growth in the coming years can be associated with the escalation in sedentary lifestyle habits, the increasing incidence of secondary osteoporosis, the advent of virtual bone fracture clinics, gene therapies for osteoporosis, and heightened attention towards bone health in men. The expectation for the market in the forecast period also notes significant developments in biologic treatments, the incorporation of artificial intelligence, the use of blockchain for bone health data, and the integration of machine learning.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

How are the latest trends influencing the growth of the osteoporosis treatment market?
Preserving their market stance, leading companies in the osteoporosis treatment market are focusing on the innovation of advanced osteoporosis treatments that are injectable. These injections, used as a preventative measure against bone loss and as a reduction tactic for fractures in osteoporosis sufferers, offer a direct way to bolster bone density and enhance skeletal health. Apotex Corp., a pharmaceutical firm based in Canada, for instance, released the Teriparatide Injection in November 2023. Specifically designed for single-patient use in osteoporosis treatment, this pre-filled pen contains a concentration of 250 mcg/mL and provides 28 daily 20 mcg doses per pen. The company aim with this product is to facilitate accessible, affordable treatment for the approximately 10 million Americans living with osteoporosis. Its production highlights Apotex's commitment to creating intricate generic medications and ensuring that patients have access to top-quality treatment.

Which key market segments comprise the osteoporosis treatment market and drive its revenue growth?
The osteoporosis treatment market covered in this report is segmented -

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
2) By Route Of Administration: Oral, Injectable, Other Routes
3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations
3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)
4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene
5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues
6) By Rank Ligand (RANKL) Inhibito: Denosumab

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

What regions are at the forefront of osteoporosis treatment market expansion?
North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the osteoporosis treatment market?
Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy's Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

What Is Covered In The Osteoporosis Treatment Global Market Report?

• Market Size Forecast: Examine the osteoporosis treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the osteoporosis treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the osteoporosis treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the osteoporosis treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the osteoporosis treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the osteoporosis treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the osteoporosis treatment market.
• Competitive Landscape: Review strategic developments in the osteoporosis treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.